Literature DB >> 403861

Isolation and molecular size of Clostridium botulinum type C toxin.

B Syuto, S Kubo.   

Abstract

A procedure is described for the purification of hemagglutinin-free Clostridium botulinum type C toxin. The toxin was purified approximately 1,000-fold from the original culture supernatant in an overall yield of 60% to a final specific toxicity of 4.4 x 10(7) minimal lethal doses/mg of protein. The toxin had a molecular weight of 141,000 and consisted of a heavy and a light chain. The molecular weights of the subunits were approximately 98,000 and 53,000. When comparing the molecular size and composition of type C toxin to that of botulinum toxins of different types, some common features may be suggested; i.e., the toxin has a molecular weight between 141,000 to 160,000 and is comprised of a heavy and a light chain linked by disulfide bonds (or bond).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403861      PMCID: PMC170697          DOI: 10.1128/aem.33.2.400-405.1977

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

2.  The role of sulfhydryl groups in the activity of type A botulinum toxin.

Authors:  J Knox; W P Brown; L Spero
Journal:  Biochim Biophys Acta       Date:  1970-08-21

3.  Isolation of chromatographically pure toxin of Clostridium botulinum type B.

Authors:  B R DasGupta; D A Boroff; K Cheong
Journal:  Biochem Biophys Res Commun       Date:  1968-09-30       Impact factor: 3.575

4.  Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration.

Authors:  B R DasGupta; D A Boroff
Journal:  J Biol Chem       Date:  1968-03-10       Impact factor: 5.157

5.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

6.  Isolation and characterization of Clostridium botulinum type B toxin.

Authors:  W H Beers; E Reich
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Immunoaffinity chromatography of proteins.

Authors:  D M Livingston
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

8.  Purification and crystallization of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Jpn J Vet Res       Date:  1972-06       Impact factor: 0.649

9.  Purification and properties of Clostridium botulinum type F toxin.

Authors:  K H Yang; H Sugiyama
Journal:  Appl Microbiol       Date:  1975-05

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  24 in total

1.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Purification and characterization of ADP-ribosyltransferases (exoenzyme C3) of Clostridium botulinum type C and D strains.

Authors:  K Moriishi; B Syuto; N Yokosawa; K Oguma; M Saito
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

3.  Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Oguma; A Nakane; H Iida
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

4.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

5.  Cloning of the structural gene for Clostridium botulinum type C1 toxin and whole nucleotide sequence of its light chain component.

Authors:  K Kimura; N Fujii; K Tsuzuki; T Murakami; T Indoh; N Yokosawa; K Oguma
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

6.  Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.

Authors:  J Terajima; B Syuto; J O Ochanda; S Kubo
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

7.  Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms.

Authors:  K Moriishi; B Syuto; M Saito; K Oguma; N Fujii; N Abe; M Naiki
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  J O Ochanda; B Syuto; K Oguma; H Iida; S Kubo
Journal:  Appl Environ Microbiol       Date:  1984-06       Impact factor: 4.792

9.  Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).

Authors:  M Matsuda; K Ozutsumi; P Y Du; N Sugimoto
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.